TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,695,062 | -61.1% | 972,602 | -33.1% | 1.42% | -53.7% |
| Q2 2023 | $22,344,653 | -36.5% | 1,454,730 | -7.0% | 3.07% | -32.3% |
| Q1 2023 | $35,165,252 | +299.9% | 1,563,595 | +274.0% | 4.54% | +236.5% |
| Q4 2022 | $8,792,622 | -14.4% | 418,099 | +0.3% | 1.35% | -37.7% |
| Q3 2022 | $10,268,000 | -65.7% | 416,729 | -66.3% | 2.16% | -71.7% |
| Q2 2022 | $29,928,000 | +33.3% | 1,235,151 | +41.8% | 7.64% | +5.0% |
| Q1 2022 | $22,444,000 | +297.1% | 870,918 | +378.3% | 7.28% | +141.0% |
| Q4 2021 | $5,652,000 | – | 182,103 | – | 3.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |